Hematologically Important Mutations: X-Linked Chronic Granulomatous Disease (Second Update)
- 1 January 2001
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 27 (1) , 16-26
- https://doi.org/10.1006/bcmd.2000.0347
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Hematologically Important Mutations: The Autosomal Recessive Forms of Chronic Granulomatous Disease (First Update)Blood Cells, Molecules, and Diseases, 2000
- Nonhomologous Recombination between the Cytochrome b558Heavy Chain Gene (CYBB) and LINE-1 Causes an X-Linked Chronic Granulomatous DiseaseGenomics, 1998
- Human Peripheral Eosinophils Have a Specific Mechanism to Express gp91-phox, the Large Subunit of Cytochrome b558Biochemical and Biophysical Research Communications, 1995
- Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558.Journal of Clinical Investigation, 1994
- A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.Journal of Clinical Investigation, 1994
- The Genetic Basis of Chronic Granulomatous DiseaseImmunological Reviews, 1994
- A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous diseaseEuropean Journal of Pediatrics, 1993
- Studying X inactivationThe Lancet, 1992
- Molecular Genetics of Chronic Granulomatous DiseaseAnnual Review of Immunology, 1989
- Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal locationNature, 1986